Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT is entering new markets $$$...

<< Previous

Bullboard Posts

Next >>

Post by wildbird1on Jul 01, 2024 11:25am

397 Views

Post# 36113297

TLT is entering new markets $$$...

Up until now TLT market potential $value was almost exclusively...Bladder Cancer market=$5 Billion/year.

Lately 3 more very lucrative markets have been added(because of ''Combination Therapy'').
1) Chemotherapy Cancer market= $157 billion/year.
2) Lung Cancer market = $ 29 billion/year.
3) Immunotherapy cancer market= $126 billion/year.

When TLT will sign one(or more) Big Pharma deal, these ''Combinaison Therapy'' potential $value will certainly be discussed.

The future looks great.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing